Total assets · 2011–2025
Sinovac Biotech total assets
$8.5B−30.8% · FY2025
Sinovac Biotech (SVA) reported $8.5B in total assets for fiscal 2025, −30.8% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $8.5B | −30.8% | Open → |
| FY20242024-12-31 | $12.3B | −9.4% | Open → |
| FY20232023-12-31 | $13.6B | −3.0% | Open → |
| FY20222022-12-31 | $14.0B | −16.3% | Open → |
| FY20212021-12-31 | $16.8B | +781.4% | Open → |
| FY20202020-12-31 | $1.9B | +320.4% | Open → |
| FY20192019-12-31 | $452M | +22.3% | Open → |
| FY20182018-12-31 | $370M | +23.6% | Open → |
| FY20172017-12-31 | $299M | +41.6% | Open → |
| FY20162016-12-31 | $211M | +4.2% | Open → |
| FY20152015-12-31 | $203M | −14.9% | Open → |
| FY20142014-12-31 | $239M | −0.9% | Open → |
| FY20132013-12-31 | $241M | +15.3% | Open → |
| FY20122012-12-31 | $209M | −3.3% | Open → |
| FY20112011-12-31 | $216M | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +30.0%
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Sinovac Biotech total assets |url=https://companiesranked.com/en/company/sinovac-biotech/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Sinovac Biotech total assets. CompaniesRanked. https://companiesranked.com/en/company/sinovac-biotech/total-assetsBibTeX
@misc{companiesranked-en-company-sinovac-biotech-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Sinovac Biotech total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/sinovac-biotech/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-258534 · June 5, 2026
{{cite web |title=Sinovac Biotech total assets — 20-F (0001193125-26-258534) |url=https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.